Accelerate Diagnostics, Inc. (AXDX) News

Accelerate Diagnostics, Inc. (AXDX): $0.56

-0.03 (-4.33%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter AXDX News Items

AXDX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

AXDX News Highlights

  • AXDX's 30 day story count now stands at 6.
  • Over the past 27 days, the trend for AXDX's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about AXDX are BEAT and SRTS.

Latest AXDX News From Around the Web

Below are the latest news stories about Accelerate Diagnostics Inc that investors may wish to consider to help them evaluate AXDX as an investment opportunity.

Accelerate Diagnostics scheduled call to review 2021 fourth quarter and full year results

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Wednesday, March 8, 2022, at 4:30 p.m. Eastern Time to review 2021 fourth quarter and full year financial results.

Yahoo | February 24, 2022

Accelerate Diagnostics (AXDX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 15, 2022

Sensus Healthcare, Inc. (SRTS) Beats Q4 Earnings and Revenue Estimates

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 128.57% and 18.31%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 10, 2022

Accelerate Diagnostics to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16, 2022, at 10:00 a.m. Eastern Time

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that the company is scheduled to present virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16, 2022, at 10:00 a.m. Eastern Time.

Yahoo | February 2, 2022

What Is The Ownership Structure Like For Accelerate Diagnostics, Inc. (NASDAQ:AXDX)?

Every investor in Accelerate Diagnostics, Inc. ( NASDAQ:AXDX ) should be aware of the most powerful shareholder groups...

Yahoo | January 31, 2022

Ironwood Financial, llc Buys Accelerate Diagnostics Inc, Vanguard Total Stock Market ETF, ...

Investment company Ironwood Financial, llc (Current Portfolio) buys Accelerate Diagnostics Inc, Vanguard Total Stock Market ETF, Vanguard Total World Stock ETF, Vanguard FTSE Developed Markets ETF, Schwab U.S.

Yahoo | January 28, 2022

Accelerate Diagnostics slips 3% as prelim 4Q FY21 revenue expected to be below consensus

Accelerate Diagnostics (AXDX) slips 3% as 4Q revenue is expected to be ~$3.3M (consensus $3.75M) compared to $3.1M in 4Q20.FY21 revenue is expected to be $11.8M (consensus…

Seeking Alpha | January 13, 2022

Accelerate Diagnostics Announces Preliminary Fourth Quarter & Full-Year 2021 Financial Results

Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced preliminary financial results for the quarter and year ending December 31, 2021. Highlights for the fourth quarter and full-year 2021 are presented below.

Yahoo | January 13, 2022

Accelerate Diagnostics Wins Suzhou Innovation Award to Support Continued China Commercialization Efforts

Accelerate Diagnostics, Inc. (Nasdaq: AXDX) announced today that it was honored as a recipient of China's Suzhou Industrial Park's (SIP) 15th Science and Technology Leaders Innovation Award for the Company's Accelerate Pheno® System.

Yahoo | January 12, 2022

Accelerate Diagnostics to Participate Virtually in 40th Annual J. P. Morgan Healthcare Conference on January 13, 2022

Accelerate Diagnostics, Inc. (Nasdaq: AXDX) announced today that the company is scheduled to present at the 40th Annual J. P. Morgan Healthcare Conference on January 13, 2022, at 9:45a.m. Eastern.

Yahoo | December 29, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.529 seconds.